A carregar...
Metabolic complications with the use of mTOR inhibitors for cancer therapy
BACKGROUND: mTOR inhibitors are now approved by regulatory agencies for the treatment of a variety of malignancies. The risk of metabolic complications with these agents is not well characterized. METHODS: PubMed was searched for articles published from 2001 until 2011. Eligible studies included pro...
Na minha lista:
| Publicado no: | Cancer Treat Rev |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744486/ https://ncbi.nlm.nih.gov/pubmed/23684373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctrv.2013.04.005 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|